The questions that separate a responsible regenerative consultation from a sales pitch: product identity, regulatory status, evidence, consent, and independent review.
Stem cell therapy is a label covering very different products and procedures. This guide gives you the questions to ask, the FDA context to know, and what a careful consultation looks like.
Reviewed by Editorial and clinical review pending
Few phrases in modern wellness carry more promise and less precision than stem cell therapy. The label is applied to profoundly different products, procedures, and evidence levels, which means the label alone tells you almost nothing about what is actually being offered. RINOVA Longevity treats stem cells as an individualized conversation rather than a menu item, and this guide is built to serve that conversation: the questions worth asking, the regulatory context worth knowing, and the signs that distinguish careful medicine from confident marketing.
Start every regenerative conversation with product identity. What material is being proposed, from what source, processed how, and does it actually contain living cells? Which laboratory or manufacturer supplies it, and what documentation exists? Words like regenerative, biologic, cellular, and stem cell get used interchangeably in marketing. A provider who welcomes these questions and answers them specifically is showing you something important. A provider who retreats to the category name is showing you something too. Write the answers down, including the exact product name.
The FDA has been direct on this topic. Its consumer update, FDA Warns About Stem Cell Therapies, explains that many stem cell products marketed to consumers are unapproved, that approval for one use does not transfer to other uses, and that unproven products have caused serious harm in documented cases. Reading it before any consultation, anywhere, is the single highest-value ten minutes in this entire subject. Ask whether the specific product proposed to you is FDA-approved for the proposed use, offered within a registered clinical trial, or neither, and ask to see the answer in writing. If a provider dismisses the agency guidance outright rather than engaging with it, weigh that reaction heavily.
Regenerative medicine is a genuinely promising research field, and that promise is exactly what unproven marketing borrows. Hold the line between the two. Claims that one product treats many unrelated conditions, promises to reverse aging, guarantees of tissue regrowth, and walls of patient testimonials are all reasons for more skepticism, not less. Testimonials in particular establish nothing about safety or effectiveness; they establish that someone said something on camera.
Certain patterns repeat across regenerative marketing often enough to be worth listing plainly. Treat the appearance of any of these as a reason to slow down: one product offered for a long menu of unrelated conditions; urgency mechanics such as limited slots or same-day discounts; heavy reliance on testimonials and before-and-after anecdotes; hostility or evasiveness when you ask for the product name, supplier, or documentation; claims that regulators are simply behind the science; and pressure to pay large sums up front. None of these proves bad faith on its own. Several together form a picture, and the picture is the point. Careful medicine rarely needs to hurry you.
A responsible regenerative consultation spends most of its time on your situation: history, prior evaluations, what has and has not been tried, and what a meaningful outcome would be. Consent, if anything proceeds, should cover known and unknown risks, realistic alternatives including established care, total cost, aftercare, follow-up, and who manages complications. You should leave with documents, time to think, and zero pressure to decide in the room. Deposit-today discounts have no place in medical decisions.
It is easier to read questions off a phone than to compose them in an exam room, so bring these written down. What exactly is the product, and who supplies it? Is it approved for my proposed use, in a registered trial, or neither? What written evidence exists for this product and this use? What are the known risks, and who manages a complication? What are my alternatives, including established care and doing nothing? What is the total cost, start to finish? When do we reassess, and against what measure? A provider worth your trust will treat that list as a good sign, not an interrogation.
For any invasive or expensive regenerative proposal, an opinion from a qualified clinician with no stake in the sale is worth the extra appointment. Bring the product details and consent paperwork. An independent reviewer can pressure-test the diagnosis, the evidence, and the alternatives, and a trustworthy provider will encourage rather than resent that step. Your primary care physician is a reasonable first stop, and for orthopedic or neurological questions, the relevant specialist is better still.
RINOVA frames Stem Cells as a highly personalized conversation about goals, fit, and appropriate next steps, which sometimes means the appropriate next step is not a regenerative product at all. Related services such as Peptide Therapy and IV Therapy carry their own separate evidence and risk profiles and should never be bundled into one sweeping regenerative story. Use the first-visit request to ask which licensed clinician leads the consultation and what records to bring. Arrive with this guide in mind and every question in it.
This article is for educational purposes only and is not medical advice. RINOVA's clinical team can help you decide whether a treatment is appropriate for your goals, health history, and care plan.
This guide is educational and is not medical advice. Personal fit, contraindications, and treatment cadence should be reviewed with a qualified professional before beginning any wellness routine.
Questions
Its exact identity: source material, processing method, whether it contains living cells, the supplying laboratory or manufacturer, the route of administration, and the documentation behind all of it.
Approved uses are narrow and specific, and the FDA has warned that many products marketed to consumers are unapproved. Ask whether the specific product is approved for the specific proposed use, in a registered trial, or neither.
No. Testimonials establish nothing about safety or effectiveness. Evidence means studies specific to the product and use, plus regulatory status you can verify independently.
Yes, especially for anything invasive or expensive. A qualified clinician with no financial stake can pressure-test the diagnosis, evidence, and alternatives, and good providers welcome that step.
An individualized review of goals, history, and fit, overseen by the RINOVA medical director, which may conclude that a regenerative product is not the appropriate next step. No outcome is promised or assumed.